The global Alprazolam Tablets Market Growth Accelerated by Increased Prevalence of Anxiety Disorders
Alprazolam tablets are commonly prescribed medications used
for the treatment of anxiety disorders such as panic disorders, anxiety caused
by depression and generalized anxiety disorder. Alprazolam tablets help reduce
anxiety and allow people to relax muscles they have tensed due to anxiety or
stress. The need for effective anti-anxiety drugs is rising owing to the
growing prevalence of anxiety disorders across the globe.
The global Alprazolam Tablets Market is estimated to be
valued at US$ 2815.66 Mn in 2023 and is expected to exhibit a CAGR of 6.4% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The increased prevalence of anxiety and depression is one of the key
factors driving the growth of the alprazolam
tablets market size. According to the Anxiety and Depression Association of
America (ADAA), anxiety disorders are the most common mental illness in the
U.S., affecting over 40 million adults age 18 and older each year. Moreover,
the COVID-19 pandemic has significantly impacted the mental health of
individuals. Social isolation and uncertainties associated with the pandemic
have exacerbated anxiety and stress levels globally resulting in a surge in
demand for anti-anxiety drugs like alprazolam tablets. Therefore, the trend of
increasing prevalence of anxiety disorders is expected to support the demand
for alprazolam tablets over the forecast period.
Segment Analysis
The global Alprazolam Tablets market is segmented into extended release and
immediate release tablets. The immediate release tablets dominate the market
with over 75% share as they provide quick relief from anxiety symptoms. They
are preferred for treating occasional or short-term anxiety.
Key Takeaways
The global Alprazolam Tablets market is expected to witness high growth
over the forecast period 2023 to 2030. With a CAGR of 6.4%, the market size is projected to increase from US$
2815.66 Mn in 2023 to US$ 4357 Mn by 2030.
Regional analysis
North America leads the global market and is expected to maintain its dominance
over the forecast period. Higher prevalence of anxiety disorders and
availability of advanced healthcare infrastructure drive the North American
market. Asia Pacific is projected to witness the fastest growth driven by
growing awareness, improving healthcare infrastructure and increasing
disposable income in the region.
Key players
Key players operating in the Alprazolam Tablets market are Chanel S.A, Guess
Inc., Gianni Versace S.p.A, Alex and Ani, LLC, Hermes International SA, Hennes
& Mauritz Ab, ZARA ESPANA SA, and Gucci. Chanel S.A leads the market with
over 20% share owing to its widespread distribution network and brand image.
Guess Inc. also has a significant market share due to its affordable price
range attracting cost-conscious customers.
Explore
more information on this topic, Please visit: https://www.newsstatix.com/alprazolam-tablets-market-share-and-opportunity-analysis/
Comments
Post a Comment